Cypre
About:
Cypre Inc. is a biotechnology company developing novel 3D in vitro models of the tumor microenvironment (TME) for cancer drug discovery.
Website: http://www.cypre.co
Description:
Cypre Inc. is a biotechnology company developing novel 3D in vitro models of the tumor microenvironment (TME) for cancer drug discovery. The company employs proprietary high content imaging algorithms and in-house built 3D hydrogel technology to map efficacy and novel insights to therapeutic mechanisms across all modalities - small molecules, antibodies, and cell & gene therapy.
Total Funding Amount:
$1.13M
Estimated Revenue Range:
Less than $1M
Headquarters Location:
San Francisco, California, United States
Founded Date:
2016-01-01
Founders:
Kolin Hribar
Number of Employees:
11-50
Last Funding Date:
2022-10-22
IPO Status:
Private
Industries:
© 2025 bioDAO.ai